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Abstract 
OBJECTIVE: To determine whether the availability of mammography resources affected breast cancer 
incidence rates, stage of disease at initial diagnosis, mortality rates and/or mortality-to-incidence 
ratios throughout Mississippi. METHODS: Mammography facilities were geocoded and the numbers of 
residents residing within a thirty minute drive of a mammography facility were calculated. Other data 
were extracted from the Mississippi Cancer Registry, the U.S. Census, and the Mississippi Behavioral 
Risk Factor Surveillance Survey (BRFSS). RESULTS & DISCUSSION: There were no statistically-significant 
differences between breast cancer incidence rates in Black versus White females in Mississippi; 
however, there were significant differences in the use of mammography, percentages of advanced-
stage initial diagnoses, mortality rates, and mortality-to-incidence ratios, where Black females fared 
worse in each category. No statistically-significant correlations were observed between breast cancer 
outcomes and the availability of mammography facilities. The use of mammography was negatively 
correlated with advanced stage of disease at initial diagnosis. By combining Black and White subsets, 
a correlation between mammography use and improved survival was detected; this was not apparent 
in either subset alone. There was also a correlation between breast cancer mortality-to-incidence 
ratios and the percentage of the population living below the poverty level. CONCLUSIONS: The 
accessibility and use of mammography resources has a greater impact on breast cancer in Mississippi 
than does the geographic resource distribution per se. Therefore, intensified mammography 
campaigns to reduce the percentage of advanced-stage breast cancers initially diagnosed in Black 
women, especially in communities with high levels of poverty, are warranted in Mississippi. 
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Introduction 
Breast cancer is the most frequently-occurring cancer in women; fortunately, breast cancer 
mortality rates have steadily declined in the United States since 1990 [1,2]. This decline appears 
to have resulted from the combined benefits of the increased use of screening mammography and 
adjuvant therapy. However, improvements in breast cancer survival have not been uniform in all 
populations and in all geographic regions throughout the nation. Most notably, despite their 
lower incidence rates for breast cancers, Black women die from these diseases at higher rates 
than do White women, and this trend has persisted for many years [3]. Given that approximately 
37% of Mississippians are of African ancestry, the disparate outcomes affecting African-
American women may have a significant impact on Mississippi's cancer burden. An important 
aim of this study is to compare cancer outcomes between Black and White female Mississippi 
residents and to explore the possible reasons for the differential outcomes. However, there are 
other demographic characteristics of particular relevance to Mississippi, and these too may result 
in a worsened overall impact due to breast cancer mortality rates. Relative to the other states in 
America, Mississippi has one of the lowest levels of educational attainment [4] and lowest rates 
of high school graduation [5]. Mississippi has chronically ranked as one of the poorest states in 
the USA, whether measured by childhood poverty rates [6], median household income
1
 or by 
percentage of the population living below poverty level [7]. It has been well-documented that 
low socio-economic status (SES) parameters such as literacy and income [8,9] are generally 
associated with higher cancer mortality rates, and this is also true for breast cancer mortality 
rates [10]. To better understand how SES parameters can affect breast cancer mortality rates, 
much research has been invested in understanding the relationships between SES and specific 
aspects of health care consumption and delivery. This is a complicated issue, and these 
relationships may not be preserved in all geographic locations, because health care systems are 
subject to regional variations. In fact, some studies suggest that, although early-stage cancers are 
less likely to be detected in poor areas due to decreased mammography rates, this has no overall 
bearing on breast cancer survivorship [11]. 
Some aspects of racial disparity are difficult to understand. For example, Maly and co-workers 
described a pronounced disparity in the diagnostic delay between Black women and White 
women with breast cancer, regardless of whether their breast abnormalities were initially self-
detected or detected by health care providers [12]. A study conducted with a South Carolina 
cohort also found racial disparities in the interval time between the first abnormal clinical breast 
examination and determination of final status in economically-disadvantaged Black versus White 
women, although there was no significant disparity associated with overall completion of 
mammographic work-up [13]. It is unclear why such delays should be greater for Black women 
with breast cancer than for comparable White women. 
In addition to the socio-economic factors that might contribute to racial disparities in breast 
cancer outcomes, one must also consider the influence of biological factors contributing to these 
disparities. There are a variety of breast cancer subtypes which can be distinguished by their 
gene expression profiles, and these subtypes correlate with differing clinical outcomes [14,15]. 
For example, patients with the luminal A breast cancer subtype have very good survival 
prospects, and approximately 90% of such patients can expect to be long-term survivors. In 
contrast, patients with the basal-like breast cancer subtype have the least favorable survival odds, 
and may not survive longer than four years post-diagnosis. The immunohistochemical tools 
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routinely used by clinical pathology laboratories to verify the presence of estrogen receptor α, 
progestin receptor B and HER2/Neu (human epidermal growth factor receptor 2) have been 
useful in identifying major breast cancer subtypes in patients. The luminal A and B subtypes 
both express estrogen receptor α, for example, which indicates that these tumors may respond to 
endocrine therapy with aromatase inhibitors or selective estrogen receptor modulators (SERMs). 
HER2 amplification and overexpression is a significant diagnostic feature which indicates that a 
tumor may respond to trastuzumab, lapatinib or pertuzumab therapy. The basal-like breast cancer 
subtype, in contrast, often presents with an immunohistochemically "triple-negative" phenotype, 
i.e., these breast cancers lack immunoreactivity for estrogen receptor α, progestin receptor B and 
do not contain genomic amplification of HER2/Neu. Basal-like tumors can be treated with 
chemotherapy, but a substantial fraction of these tumors respond poorly to therapy and have a 
poor prognosis. 
Over a decade has passed since five breast cancer subtypes (Luminal A, Luminal B, Normal-like, 
Basal-like and Her2-enriched) were first identified by distinctive gene expression profiles, and 
during that interval much has been learned about how these subtypes may contribute to the 
population-based disparities in breast cancer mortality. It is now well-established that not all 
populations possess an equal distribution of these subtypes. Recently, genome-wide association 
studies identified a common risk variant for ER-negative breast cancer on chromosome 5p15, 
and the allele frequency of this variant was nearly twice as high in women of African ancestry as 
it was for women of European ancestry [16]. “Triple-negative” breast cancers [TNBC] 
themselves are a highly heterogeneous group that may include up to 6 different subtypes (Basal-
like 1, Basal-like 2, Mesenchymal, Mesenchymal Stem-like, Immunomodulatory and Androgen-
receptor enriched) that respond differently to treatment [17,18]. It is still unknown whether these 
subtypes are differently distributed among different ethnic groups. TNBCs are disproportionately 
observed in women of African ancestry. This observation has been corroborated in numerous 
U.S. studies, including those based on the California Cancer Registry [19,20], the Carolina Breast 
Cancer Study [21,22], a Thomas Jefferson University Hospital cohort [23] and the SEER database 
[23]. The high prevalence of these aggressive cancers in women of African ancestry is a 
worldwide phenomenon and is clearly rooted in biological diversity. In one study the prevalence 
of "triple-negative" breast cancers in Ghanian women was reported to be as high as 82% versus a 
16% prevalence in American women of European ancestry [24]. While the prevalence of triple-
negative/basal-like breast cancer is clearly higher in women of African versus European 
ancestry, it appears that the prognosis for survival may be equally grim for women of all races 
and ethnicities afflicted by this aggressive cancer subtype, but only when patient cohorts are 
properly matched for other factors that affect survival [25,26]. 
In addition to research that focuses on TNBC breast cancer subtypes, other research has 
investigated other possible biological explanations of population-based breast cancer mortality 
disparities. One group has observed more extensive CpG island methylation in the promoters of 
the RASSF1A, RARβ2 and CDH13 loci in tumors taken from women of African versus European 
ancestry [27]. Methylational silencing of tumor suppressor genes commonly occurs through such 
mechanisms. Since these authors also observed an association between worse overall survival 
and higher methylation in these loci, they suggested that their discovery would be consistent with 
a biological explanation of disparity [27]. 
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As stated earlier, a major factor in the national decline in breast cancer mortality has been the 
increasing use of screening mammography. Based on this evidence [28], the U.S. Preventive 
Services Task Force (USPSTF) recommended mammography screening every 1 to 2 years for 
women age 40 years and older in 2002 [29]. In 2009, however, the USPSTF recommended 
against routine mammography screening for women age 40 – 49, and they also recommended 
against clinicians teaching women how to perform breast self-exams [30]. These changes in 
USPSTF recommendations were not without controversy, and several responses and rebuttals to 
the 2009 USPSTF recommendations have been noted. Despite the new USPSTF 
recommendations, the majority of primary care physicians favor aggressive mammography 
screening of women from ages 40 to 79 [31]. The American Cancer Society continues to advise 
average-risk women to begin mammography screening at age 40, and they also recommend 
clinical breast exams every three years for women between the ages of 20 to 39 [32]. 
However, mammography is a capital-intensive diagnostic procedure, and in a poor (relative to 
U.S. standards) rural state such as Mississippi, it may be difficult for all women to have easy 
access to mammography facilities. One should bear in mind that there are two aspects to be 
considered: availability and accessibility. Resource availability refers to the physical presence of 
that resource; because all mammography facilities must be certified by the U.S. F.D.A, one can 
literally map mammography availability throughout the state. Resource accessibility refers to the 
ability of a given individual to use that resource; this can be a much more complex aspect to 
quantify because it encompasses socioeconomic barriers to use, such as transportation to the 
resource, ability to pay for resource use, etc. 
In this manuscript we examine publicly-accessible data concerning breast cancer in Mississippi 
to determine whether the geographic distribution of mammography facilities has a discernible 
effect on breast cancer outcomes in the state. The hypothesis to be tested is that limited 
availability of mammography facilities limits the accessibility of these resources, which results 
in an increased advanced stage at initial diagnosis and increased breast cancer mortality. 
Methods 
Spatial Analysis 
Spatial analysis in this project involved delineating areas within 30-minute drive time distance 
from the mammography facilities and then identifying demographic characteristics within and 
outside the drive time areas by apportioning data from Census Block Groups. A spreadsheet for 
mammography facilities with data from the U.S. Food and Drug Administration's Mammography 
Facility Database (http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmqsa/mqsa.cfm) was 
prepared to geocode using ArcGIS 10.1 (Environmental Systems Research Institute, Inc., 
Redlands, California). A map was created showing the location of the geocoded facilities along 
with the counties and major transportation network in Mississippi (Figure 1). Using the same GIS 
software areas within and outside the drive time distance in respect to all mammography 
facilities were identified based on optimum driving route. Since facilities from neighboring states 
that are within the desired drive time distance (30 minute) can serve Mississippians, facilities 
from all neighboring states were taken into account for this analysis (Figure 2). This drive time 
distance area was also used to calculate the % female outside the desired distance from the 
mammography facility per public health district in Mississippi (Table 2). The delineated areas 
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were superimposed on Census geography (Block Group) to proportionately apportion the 
demographic data from Census geography to drive time distance area geography. Demographic 
attributes were obtained from the 2010 U.S. Census data. 
MCR Breast cancer data 
Breast cancer incidence and mortality data were obtained from the Mississippi Cancer Registry 
(http://mcr.umc.edu/) over the years 2005 through 2009 to provide a more reliable "snapshot" of 
recent cancer statistics in a state dominated by low population density areas. Mississippi has a 
fairly stable population, as evidenced by U.S. Census data showing that the 0.3% change in 
population in Mississippi from 2010 to 2011 was below the national average of 0.9%, and 
population changes for individual Mississippi counties ranged from -3.0% to 3.2%. Breast cancer 
data were derived from only the female cohort because mammography is not a recommended 
screening modality for males. Mississippi's Behavioral Risk Factor Surveillance System 
(BRFSS) Public Health District survey report (http://msdh.ms.gov/brfss/index.htm) was the 
source of data on the use of mammography in women aged 40 and above were obtained from the 
District Reports for the years 2005, 2006 and 2008 (this question is not annually included in the 
BRFSS). 
Data Analysis 
Histograms were constructed for the cancer outcome, mammography usage and socio-economic 
variables to examine the normality of the distributions. Correlation analysis was performed 
between cancer outcome variables and mammography usage or socio-economic variables to 
assess the degree of association. The Pearson correlation coefficient was evaluated when both 
variables were normally distributed. If one variable or both variables had skewed distribution, 
the Spearman rank correlation coefficient was utilized. Comparison of cancer outcome variables 
between Black and White women residents was performed using the two-sample T test. All p 
values were two-sided and p values less than 0.05 were considered significant. Statistical 
analysis was performed using the software SAS (version 9.3, SAS Institute Inc.). 
Results 
The GIS mapping of FDA certified mammography facilities in Mississippi is shown in Figure 1. 
The densest clustering of mammography facilities was located along major Interstate highways. 
For example, thirteen mammography facilities were on the I-10 corridor that passes through 
Hancock, Harrison and Jackson Counties along the Gulf Coast, whereas there was only one 
mammography facility not adjacent to an Interstate highway in the three counties (Pearl River, 
Stone and George Counties) immediately to the north. Interstate-55 and Interstate-20 intersect in 
Jackson, Mississippi, and there were sixteen mammography facilities in the tri-county region 
(Hinds, Madison and Rankin Counties) which defines the greater Jackson Metropolitan Area. In 
addition to these sixteen facilities, there were seven on I-55 North, four along I-55 South, two on 
I-20 West and five on I-20 East. Five additional mammography facilities were found along the I-
59 corridor through Jones, Forrest, Lamar and Pearl River Counties. Thus, of the ninety FDA-
certified mammography facilities in Mississippi, 52 (57.8%) were located along the Interstate 
highway system. 
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Figure 1. Map of FDA-certified mammography facilities in Mississippi. The U.S. Food and 
Drug Administration Mammography Facilities database was searched to identify the geographic 
address of all 90 mammography facilities in Mississippi. These are shown as red crosses on the 
map, which contains references to the 82 counties of Mississippi and the Interstate highway 
system. (http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmqsa/mqsa.cfm) 
We then sought to estimate how many Mississippi women had convenient access to these 
facilities, assuming that all women had equal access to automobile transportation. Using the 
ArcGIS 10.1 software package (Environmental Systems Research Institute, Inc., Redlands, 
California), we calculated the drive time area in which a driver could travel to a mammography 
facility within thirty minutes for each facility. These 30-minute drive time areas for Mississippi 
and its neighboring states are shown in green and purple in Figure 2. Because women who live 
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near the state border might choose to travel to mammography facilities outside of Mississippi, 
we also calculated these 30-minute driving buffer areas for mammography facilities in the 
neighboring states Louisiana, Arkansas, Tennessee and Alabama which are shown in purple. By 
integrating the land areas covered within these buffer areas, one can see that 54% of Mississippi 
was within a thirty minute drive to a mammography facility. In comparison, 58% of Louisiana, 
43% of Arkansas, 76% of Tennessee and 71% of Alabama were situated within a thirty minutes' 
drive time to a mammography facility. 
 
Figure 2. Geographic availability of mammography facilities within a thirty-minute driving 
radius. This map displays the area that can be reached within a thirty-minute automobile drive 
from each mammography facility. The green buffer zone indicates areas surrounding 
Mississippi-based facilities; purple buffers indicate areas surrounding facilities based in the 
surrounding states of Louisiana, Arkansas, Alabama and Tennessee. 
Populations are not uniformly distributed, therefore the above percentages of land area within a 
thirty minute drive were not equivalent to the percentage of women living within those buffer 
areas. To determine the percentage of women who live within a thirty-minute drive to a 
mammography facility, we used 2011 estimated population data based on the 2010 U.S. Census 
data. Using these data, one can estimate that 84.10% of Mississippi females of age 40 and above 
lived within a thirty minute drive to a mammography facility. In comparison, 94.36% of the 
females of age 40 and above in Louisiana, 83.21% of those in Arkansas, 94.50% of those in 
Tennessee and 93.04% of the females in Alabama resided within a thirty minutes' drive time to a 
mammography facility. Thus, based on both the percentage of land area and the percentage of 
the female population within a thirty-minute driving area, mammography facilities in Arkansas 
were slightly less available than they were in Mississippi, and within this five-state territory, 
mammography facilities were most available in Tennessee. These data are summarized in Table 1. 
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Table 1. Geographic distribution of mammography facilities in Mississippi and 
surrounding states. 









minute drive to 
mammography 
facility 




minute drive to 
mammography 
facility 
93.04% 83.21% 94.36% 84.10% 94.50% 
Note: The data depicted in Figure 2 are tabulated in Table 1, along with the calculated territorial area and percentage 
of residents within a thirty-minute driving distance to a mammography facility. 
Using such GIS maps, one can assess whether breast cancer outcomes were correlated to the 
geographic distribution of mammography facilities throughout Mississippi. Considering that 
Mississippi is a sparsely-populated, predominantly rural state with low population densities, 
there may be a problem of low statistical power if one uses too small of a geocoded area as the 
basis for comparison. Thus, the first analysis was conducted at the level of Mississippi's nine 
Public Health Districts (PHDs). Table 2 contains data derived from various sources which 
described certain aspects of the Public Health Districts. The data of most interest are the 
percentages of females (age 40 and above) who reside outside of a thirty-minute drive to a 
mammography facility. Using public data from the Mississippi Cancer Registry, we examined 
the age-adjusted breast cancer incidence rates and the age-adjusted breast cancer mortality rates 
over the years from 2005 to 2009 for each of the state's PHDs. We were particularly interested in 
knowing whether the availability of mammography resources had a bearing on the breast cancer 
mortality-to-incidence ratio of the entire female population within these districts. We used this 
ratio to estimate the likelihood of surviving a diagnosis of breast cancer. The percentage of breast 
cancers initially diagnosed at an advanced stage (either regional or distant disease) was also 
considered as a potentially relevant outcome of limited availability of mammography resources. 
We applied Pearson correlation analysis to the data in Table 2 in pairwise fashion, but we were 
unable to detect any statistically meaningful correlations between any of these variables and 
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breast cancer mortality rates or mortality-to-incidence ratios when applied to the entire female 
population. However, the analysis revealed a significant negative correlation between the 
percentage of women who reported having mammography and clinical breast exams and the 
percentage of women who initially presented with advanced disease at the time of their initial 
diagnosis. The Pearson sample correlation coefficient is -0.671 with a p value of 0.047 (95% CI -
0.917 to 0.030). 
Both the BRFSS data concerning mammography usage and the Mississippi Cancer Registry data 
concerning stage of disease at initial diagnosis are available as Black and White subsets, and we 
therefore re-examined these data accordingly and plotted them in Figure 3 (upper panel). It was 
immediately apparent that the data describing the Black population (blue dots) was distinctly 
different from the data describing the White population (red crosses) for all nine Public Health 
Districts (Table 2). This was confirmed by applying the two-sample t test to PHD-level data, 
which showed that four characteristics were significantly different between the Black and White 
female subpopulations: 1) the percentage of advanced-stage breast cancers detected at initial 
diagnosis (40.8% in Black women vs. 31.5% in White women; p <0.0001); 2) the percentage of 
females age 40 and older who had mammography and clinical breast exams (73.13% in Black 
women vs. 82.57% in White women; p = 0.0001); 3) the age-adjusted breast cancer mortality 
rate (33.38 per 100,000 in Black women vs. 20.16 per 100,000 in White women; p = 0.0003); 
and 4) the breast cancer mortality-to-incidence ratio (0.2442 in Black women vs. 0.1509 in 
White women; p = 0.0005). Unfortunately, in all four of these characteristics, Black females 
fared worse than White females in Mississippi, confirming that the extent of population-based 
breast cancer is pervasive throughout all nine PHDs in the state. Only one characteristic was not 
statistically different, and that is the age-adjusted breast cancer incidence rate (p = 0.735). 
Table 2. Data characteristics of female breast cancer and breast cancer screening resources 
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13 13927 130.97 24.83 0.1896 0.341 78.20% 11.65% 
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15 15308 135.15 21.73 0.1608 0.310 81.03% 8.40% 
Note: The characteristics listed in this table include the number of mammography facilities, the number of women 
per mammography facility, the age-adjusted breast cancer incidence and mortality rates, the mortality-to-incidence 
ratios, the percentage breast cancers initially diagnosed at advanced stage (regional + distant disease), the percentage 
of women (age 40 and older) who reported ever receiving a mammogram and clinical breast exam, and the 
percentage of women residing beyond a 30 minute driving distance from a mammography facilities in each of 
Mississippi's Public Health Districts. 
Given the magnitude of these disparities, we performed correlation analyses on Black and White 
subsets to determine whether the use of mammography in either Black or White women was 
correlated to advanced stage at initial diagnosis for either group. The Pearson correlation 
coefficient was -0.861 (p = 0.001, 95% CI -0.967 to -0.416) for Black women, but did not reach 
statistical significance for White women, which reflects the more homogeneous use patterns 
amongst White women throughout the state. Interestingly, when the Black and White subsets 
were recombined, the common Pearson correlation coefficient was -0.920 (p < 0.0001, 95% CI -
0.968 to -0.783), indicating a strong correlation. Only when the Black and White subsets were 
recombined was it possible to observe a significant Pearson correlation between the mortality-to-
incidence ratio and the percentage of women with advanced stage breast cancer at initial 
diagnosis (Pearson coefficient = 0.771, p =0.0001, 95% CI 0.457 to 0.906). While no significant 
correlation existed between mortality-to-incidence ratio and mammography use in either the 
Black or the White subsets, a significant correlation (Pearson correlation coefficient = -0.728, p 
< 0.0001, 95% CI -0.887 to -0.376) was observed upon recombination of these disparate subsets 
(Fig 3, lower panel). 
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Figure 3. Public Health District patterns of mammography use are inversely correlated 
with adverse breast cancer outcomes. Mississippi BRFSS Public Health District survey report 
data (http://msdh.ms.gov/brfss/index.htm) from Black female (blue dots) and White female (red 
crosses) respondents were obtained from the District Reports for the years 2005, 2006 and 2008, 
then averaged and plotted along the abscissa. UPPER PANEL: The percentage of women 
initially diagnosed with advanced stage breast cancer (defined as the sum of the percentages of 
regional and distant disease initial diagnoses over the years 2005 through 2009) calculated from 
Mississippi Cancer Registry data for each of the nine Public Health Districts 
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(http://mcr.umc.edu/documents/FemaleBreastPHDDataCombinedYears20052009new.pdf), then plotted 
against the ordinate. These Black and White subsets were subjected to a common Pearson 
analysis to obtain a correlation coefficient of -0.920 (p < 0.0001). LOWER PANEL: Age-
adjusted breast cancer incidence and mortality rates were obtained from the Mississippi Cancer 
Registry (http://www.cancer-rates.info/ms/index.php) for Black and White women over the years 
2005 through 2009 for each of the nine Public Health Districts, and the ratio of mortality-to-
incidence was calculated and plotted along the ordinate. The Pearson correlation coefficient 
between these two variables was -0.728 (p < 0.0001). 
The observation shown in Figure 3 is consistent with other published evidence that because age-
appropriate mammography is capable of detecting early-stage breast cancer, broad usage of 
screening mammography can reduce the proportion of advanced-stage breast cancers at initial 
diagnosis [33]. The problem appeared to be most severe in the Northwest Public Health District 
1, where only 62% of Black women age 40 and older reported ever having received 
mammography and clinical breast exam, and where 48% of the initial breast cancer diagnoses 
reveal advanced stage disease in Black women. It is interesting to note that at the PHD level, 
there was no statistically significant negative correlation between the percentage of women 
reporting mammography usage and the percentage of women who must drive more than thirty 
minutes to reach a mammography facility (Pearson correlation coefficient = 0.119, p = 0.769). 
Nor was there a statistically meaningful negative correlation at the PHD level between the 
percentage of advanced-stage disease at diagnosis and the percentage of women who must drive 
more than thirty minutes to reach a mammography facility (Pearson correlation coefficient = 
0.413, p = 0.281). However, one must note that we were unable to distinguish between the 
geographic availability of mammography resources for Black versus White women within any 
given geographic region, so we were unable to perform subset correlation analyses for this 
variable. Thus, if there was any effect of the availability of mammography facilities on breast 
cancer outcomes, then our analysis was inadequate to detect this effect. 
It is reasonable to assume that by examining data at the Public Health District level, important 
demographic details may be hidden due to the homogenization of small geographic tracts with 
distinctive characteristics. Using public data from the Mississippi Cancer Registry, we further 
examined age-adjusted breast cancer incidence rates and age-adjusted breast cancer mortality 
rates over the years from 2005 to 2009 for all of the state's counties. Even with this long time 
interval, data from Issaquena County must be censored because that county's population is less 
than 1700; therefore Issaquena County data will be excluded from further consideration. We 
initially applied Spearman rank correlation analysis to determine whether, at the county level, 
either breast cancer incidence, breast cancer mortality, breast cancer mortality-to-incidence ratios 
or the percentage of advanced-stage breast cancers detected at initial diagnosis were associated 
to the percentage of females age 40 and above residing outside of a thirty-minute drive to a 
mammography facility. Because this is the only variable with skewed distribution, the Spearman 
rank correlation coefficient is a suitable criterion for association assessment. The Spearman rank 
correlation coefficient for the association between the percentage of advanced-stage breast 
cancers detected at initial diagnosis and the percentage of females age 40 and above residing 
outside of a thirty-minute drive to a mammography facility was 0.208, but this association did 
not reach statistical significance (p = 0.063). Thus, neither county-level data nor PHD-level data 
can detect a statistically-significant association between the availability of mammography 
resources and stage of disease at initial diagnosis. Further analysis of county level data reveals no 
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statistically meaningful correlation between the geographic availability of mammography 
facilities (as measured by the percentage of females residing outside of a thirty-minute drive to a 
mammography facility) and either breast cancer mortality rates (p = 0.681) or the mortality-to-
incidence ratios (p = 0.984). Unfortunately, at the county level we lacked sufficient data (such as 
the BRFSS data) to measure the accessibility of mammography resources. 
When we looked for correlations between other potentially relevant parameters (% of population 
below poverty level, median household income, % high school graduates aged 25 and above, % 
Black, and % White), two statistically-meaningful correlations were observed. There was a 
moderate correlation between breast cancer mortality-to-incidence ratios and the percentage of 
the population living below the poverty level (Figure 4, lower panel). The Pearson correlation 
coefficient for these two parameters was 0.504 (95% CI 0.318 to 0.649), with a p value of 
<0.0001. There was also a moderate correlation between breast cancer mortality rates and the 
percentage of the population who are Black (Figure 4, upper panel). The Pearson correlation 
coefficient for these two parameters was 0.422 (95% CI 0.222 to 0.585), with a p value of 
<0.0001. It is very important to note that, in Mississippi, the two parameters were strongly 
correlated. The Pearson correlation coefficient between the percentage of Black residents in a 
county and the percentage of the population in that county who live below the poverty level was 
0.802 (95% CI 0.706 to 0.867), with a p value of = 0.0001. 
Based on the breast cancer disparities between Black and White women in Mississippi observed 
in the preceding Public Health District data, cancer outcome comparison between Black and 
White women using the county-level data may prove insightful. Due to the rural nature of 
Mississippi, data from several counties could not be considered in this subset analysis because 
the Black or White population in those counties was less than 1700. Therefore Benton, Choctaw, 
Franklin, George, Greene, Hancock, Issaquena, Itawamba, Perry, Stone and Tishomingo County 
data were excluded from the Black female subset, and Claiborne, Jefferson, Humphreys, 
Issaquena, Noxubee, Quitman, Sharkey, Tunica and Wilkinson County data were excluded from 
the White female subset. The two-sample t test was applied to county-level data, which 
confirmed that two characteristics were significantly different between the Black and White 
female subpopulations: 1) the age-adjusted breast cancer mortality rate (p <0.0001) and 2) the 
breast cancer mortality-to-incidence ratio (p<0.0001). Again, Black females fared worse than 
White females in Mississippi, confirming that the existence of significant population-based 
breast cancer mortality disparities in Mississippi. As observed at the Public Health District level, 
the age-adjusted breast cancer incidence rate was not statistically different between Black 
females and White females in Mississippi (p = 0.735). 
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Figure 4. County-associated parameters correlated with breast cancer mortality outcomes.  
Breast cancer incidence and survival data were obtained from the Mississippi Cancer Registry; 
demographic data were obtained from the U.S. Census 
(http://quickfacts.census.gov/qfd/states/28000.html); all Mississippi counties are represented, 
with the exception of Issaquena County. UPPER PANEL: Age-adjusted breast cancer mortality 
rates correlated with the percentage of the population who are Black; the Pearson sample 
correlation between these two variables was 0.422 (p <0.0001). LOWER PANEL: The ratios of 
BC mortality-to-incidence were correlated with the percentages of population living below 
poverty level; the Pearson sample correlation between these two variables was 0.504 (p 
<0.0001). 
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County-level subset correlation analyses confirmed several of the observations at the PHD level: 
there was no statistically-significant correlation between the availability of mammography 
resources (as measured by the % of women residing within a 30 minute drive to a mammography 
facility) and either the breast cancer incidence rate, the breast cancer mortality rate, or the 
mortality-to-incidence ratios for either the Black female or the White female subsets. Perhaps 
more importantly, the correlation between the percentage of population living below poverty 
level and the mortality-to-incidence ratio was observed for Black females (Pearson correlation 
coefficient = 0.346, p = 0.003, 95% CI 0.120 to 0.534), but surprisingly, not for White female 
subsets (p = 0.274). One must guard against over-interpretation of the latter observation because 
the "percentage of population living below poverty level" data were unadjusted for race and were 
determined at the county level. Due to the low populations at risk, some of the counties with the 
highest percentage of residents living below the poverty level in Mississippi (Claiborne, 
Jefferson, Humphreys, Noxubee, Quitman, and Sharkey counties) were excluded from the White 
female subset, which may have introduced bias against detecting the effect of poverty in this 
subset. Conversely, some of the counties with the lowest percentage of residents living below the 
poverty level (George, Stone and Itawamba counties) were excluded from the Black female 
subset, which may have introduced bias towards detecting the effect of poverty in this subset. 
This reflected of the strong correlation between race and poverty in Mississippi; a Pearson 
correlation coefficient of 0.802 (p<0.0001) exists between the percentage of population who are 
Black and the percentage of population living below the poverty level. 
Discussion 
One cannot properly assess the burden of breast cancer in Mississippi without recognizing the 
problem of population-based disparities. This study initially sought to assess whether geographic 
disparities existed based on the statewide distribution of mammography facilities, but data 
analysis quickly revealed that poverty and race were the dominant characteristics affecting 
geographic disparities in breast cancer outcomes in Mississippi. At the county level, the 
percentage of population below poverty level and the percentage of population who are Black are 
strongly correlated. Thus, it is apparent that breast cancer places a disparate burden on poor 
African-American communities in Mississippi. This study was not designed to include direct 
measures of the impact of aggressive "triple-negative" breast cancer subtypes, so one can only 
assume that it contributes to the disproportionate mortality rates observed in Black 
Mississippians, as discussed in the Introduction section. Recent analysis of national breast cancer 
data confirm that poverty and race remain as dominant risk factors in breast cancer mortality and 
that screening rates are lower in poorer women than in wealthier women [33]. The data shown in 
Figure 3 indicate that the proportion of advanced-stage breast cancers at initial diagnosis in 
African-American women could be significantly reduced through a concerted campaign to 
increase the rate of participation in mammographic breast screening in African-American women 
in Mississippi. A decrease in the proportion of breast cancers diagnosed at an advanced stage 
may affect not only mortality rates (the probability of long-term survival is strongly negatively 
correlated with stage), but also additional parameters. These include among others the cost and 
morbidity associated with treatment (advanced stage breast cancers that recur require additional 
chemotherapy, imaging and often salvage procedures such as spine stabilization, brain irradiation 
etc.). It is not entirely clear why there was no apparent correlation between the availability of 
mammography facilities and the use of mammography. Further studies designed for the county 
level of geographic resolution, or in selected communities, may identify the community-specific 
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barriers to mammographic use, and hopefully these barriers can be overcome through 
community-targeted educational outreach campaigns. 
It has been estimated that 84 women between the ages of 40 and 84 need to be screened annually 
in order to save one life from breast cancer [34]. Care must be taken to note that screening alone 
is inadequate in Mississippi if the true objective is to increase breast cancer survivorship; women 
who receive positive screening results must also receive appropriate follow-up care. A proposal 
to increase breast cancer screening participation should address whether such an effort in 
Mississippi would result in problems associated with overdiagnosis of breast cancer. By 
definition, overdiagnosis occurs through the detection of cancers that would not otherwise cause 
symptoms or death to occur within the lifetime of an individual [35]. Overdiagnosis, by itself, can 
create needless emotional stress and anxiety considered harmful to a person's wellbeing, but the 
major harm associated with the overdiagnosis of breast cancer arises from overtreatment that 
often accompanies overdiagnosis. Estimates for the overdiagnosis of breast cancer vary 
tremendously. A study of Norwegian women estimated that approximately 15% to 25% of breast 
cancer cases were overdiagnosed [36], and estimates as high as 42% overdiagnosed breast 
cancers were obtained from an Australian cohort [37]. Studies reporting overdiagnosis 
predominantly involve European populations or populations of European ancestry, and are 
focused on ductal carcinoma in situ (DCIS), a non-invasive form of breast cancer which ranges 
from low-grade to high-grade. Although DCIS is considered non-invasive, clinicians are 
currently unable to predict which specific cases of DCIS are highly likely to progress, and which 
cases are likely to remain indolent and can be safely left untreated. The increasing frequency of 
routine mammography screening is considered to be the cause of the increasing diagnosis of 
DCIS, which had an incidence of less than 2 per 100,000 women in the early 1970s and thirty 
years later, had an incidence of approximately 32 per 100,000 women [38]. Approximately 1 in 
1300 mammograms will result in a diagnosis of DCIS [39], which accounts for approximately 
20% to 25% of breast cancer diagnoses in the U.S.A. today [38]. However, there are no 
indications that overdiagnosis and overtreatment of breast cancer is currently a significant 
problem in Mississippi, where the percentage of DCIS at initial diagnosis is lower than the 
national average [33] and where the underuse of mammography appears to be linked to increased 
probability of mortality after diagnosis. 
Conclusion 
As previously discussed, one cannot properly assess the burden of breast cancer in Mississippi 
without recognizing the problem of population-based disparities. This study initially sought to 
determine whether the geographic availability of mammography resources influenced breast 
cancer outcomes, but data analysis quickly revealed that poverty and race were the dominant 
characteristics affecting geographic disparities in breast cancer outcomes in Mississippi. The data 
presented in this manuscript supports two general observations pertaining to Mississippi’s cancer 
control efforts. First, intensified mammography campaigns to reduce the percentage of 
advanced-stage breast cancers initially diagnosed in Black women are justified and warranted. 
Second, efforts are needed to ensure that once breast cancers are diagnosed, effective medical 
treatment will occur, especially for all women living in poverty. 
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Limitations 
Before discussing the above results, the following limitations of the study design should be 
noted. These studies were based on publicly available data, and as such, all health and economic 
data were analyzed in aggregate form. Data were not obtained at the individual level, so the 
interpretations and implications of the evidence are limited to broadly defined localities and 
communities. Out of respect for individual medical privacy, public cancer registry data are 
censored for statistically sparse counties, so some women with breast cancer were excluded from 
this study based on their place of residence (e.g., Issaquena County). Finally, to compensate for 
such problems associated with the low population density in many parts of Mississippi, a five-
year data collection window was used based on the assumption that the recent trends in breast 
cancer outcomes have remained reasonably stable. 
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